import React from 'react'

export default function TermsAndConditionsPage() {
  return (
    <div className="max-w-4xl mx-auto px-4 py-10 text-black bg-white">
      <h1 className="text-3xl font-bold mb-6">Master Participation & Consent Agreement</h1>
      <div className="space-y-6">
        <p className="text-sm whitespace-pre-line">
{`
This Master Participation & Consent Agreement ("Agreement") is entered into between the Participant and Nereus Technologies Private Limited, a company incorporated under the Companies Act, 2013, having its registered office at D-510, Sterling Residency ,Dollars Colony,R.M.V. Extension II Stage, Bangalore North ,Bangalore-560094, Karnataka within the jurisdiction of the Registrar of Companies, Karnataka, Ministry of Corporate Affairs, Government of India (“Company”), as of the date of digital acceptance.

SECTION 1: CONSENT AND DATA USAGE AGREEMENT
1.1 PARTIES AND PURPOSE This Agreement is entered into between you ("Participant"), a natural person of sound mind and above the age of majority, and Nereus Technologies Private Limited. The Company is engaged in developing and testing biomechanical, physiological, and movement analytics systems. The Participant hereby consents to take part in a structured performance testing session ("Session") wherein certain categories of data will be collected, processed, and utilized by the Company in accordance with this Agreement.

1.2 DEFINITIONS
“Personal Data” means any information that directly or indirectly identifies the Participant, including but not limited to name, phone number, email address, age, gender, and demographic information.
“Physiological Data” means voluntarily disclosed characteristics such as height, weight, training history, physical background, or other bodily information.
“Biomechanical Data” refers to movement, posture, kinematic and kinetic data captured through non-invasive wearable technology or digital instruments during the Session.
“Survey Data” refers to the voluntary responses provided by the Participant in the form of market research, feedback forms, product experience reports, or preference indicators.
“Recording” includes any photograph, video, screen capture, or audio recording captured during the Session by or on behalf of the Company.
“Aggregated Data” means anonymised and de-identified data derived from any of the above categories, rendered incapable of identifying the Participant.

1.3 CONSENT TO COLLECTION AND PROCESSING The Participant provides explicit and informed consent to:
Collect, process, analyse, and store their Personal Data, Physiological Data, Biomechanical Data, and Survey Data for the purposes of generating performance reports, validating internal models, system optimisation, and developing commercial offerings;
Capture Recordings during the Session for internal use by Company-employed or contract-bound professionals, including physiotherapists, doctors, and data scientists;
Store data in accordance with applicable data protection laws, including:
Section 43A of the Information Technology Act, 2000;
The Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011;
The Digital Personal Data Protection Act, 2023 and subordinate legislation issued by the Government of India.

1.4 DATA STORAGE, SECURITY, AND ACCESS CONTROL 
The Company shall:
Store all data on encrypted, access-controlled infrastructure in line with industry standards;
Restrict access to employees, contractors, or consultants subject to binding confidentiality and non-disclosure agreements;
Retain data for only as long as necessary for the purposes set out herein or as required by applicable law;
Notify Participants in the event of any data breach as per obligations under applicable law.
All Data collected pursuant to this Agreement shall be retained exclusively on servers and databases owned and controlled by the Company. Access to such Data shall be strictly restricted to duly authorised personnel acting within the scope of their official functions, and who are contractually bound by obligations of confidentiality. At no point shall such Data be stored, transmitted, or otherwise retained on any personal devices, external storage media, or digital environments not directly administered and controlled by the Company.

1.5 USE OF RECORDINGS Recordings will be used only for internal analysis, clinical validation, and system development. They will be anonymized prior to internal sharing and shall not be used for any marketing, promotional, or public-facing content without the Participant’s prior written consent through a separate Media Consent and Waiver Agreement.

1.6 THIRD-PARTY DATA USE AND AGGREGATION The Company shall not disclose any raw, individually identifiable data to third parties without express written consent.
The Participant hereby authorises the Company to:
Derive Aggregated Data from the collected information.
Share such Aggregated Data with research institutions, academic partners, commercial collaborators, or investors;
Use such Aggregated Data for system improvements, scientific reporting, commercial presentations, and industry benchmarking.
Such data shall remain de-identified and incapable of linking back to the Participant. Consent to use Aggregated Data is granted on a perpetual, royalty-free, worldwide, and irrevocable basis.

1.7 VOLUNTARY PARTICIPATION AND RIGHT TO WITHDRAW Participation in the Session is entirely voluntary. The Participant may withdraw consent at any time before the start of the Session. Once the Session commences, withdrawal shall not affect data already collected. Fees paid for the Session are non-refundable unless otherwise stated in the Company’s refund policy.

1.8 LIABILITY AND INDEMNITY The Participant agrees to:
Follow all instructions, protocols, and guidelines issued by Company personnel during the Session;
Accept responsibility for any damage to equipment caused by negligence, mishandling, or deviation from protocol;
Waive any claim against the Company for minor discomfort, fatigue, or exertion unless caused by gross negligence or willful misconduct.
To the maximum extent permitted by applicable law, the Participant agrees that their sole and exclusive remedy for any claims or disputes arising out of or related to the Session shall be limited to the value of the fees paid for participation. The Participant expressly waives the right to initiate or join any class action or collective legal proceedings against the Company. The Company disclaims liability for any indirect, incidental, consequential, or special damages arising from the Participant’s involvement in the Session.

1.9 GOVERNING LAW AND DISPUTE RESOLUTION This Agreement shall be governed by and construed in accordance with the laws in force in the Republic of India.
The courts having jurisdiction in Bengaluru, Karnataka, shall have exclusive jurisdiction over all disputes arising out of or in connection with this Agreement.
Any dispute not resolved by mutual negotiation within thirty (30) days shall be submitted to binding arbitration in accordance with the provisions of the Arbitration and Conciliation Act, 1996, as amended.
The arbitration shall be conducted by a sole arbitrator mutually agreed upon by the Parties.
The seat and venue of arbitration shall be Bengaluru, Karnataka.
The language of arbitration shall be English.
All notices, requests, or communications under this Agreement shall be made in writing and sent via email to info@nereustechnologies.com  or via registered post to the Company’s registered address.

1.10 EXECUTION AND DIGITAL ACCEPTANCE This Agreement shall be deemed executed under the Information Technology Act, 2000. By checking the consent box, the Participant affirms they are over 18, competent to contract, and accept all terms.

1.11 ASSUMPTION OF RISK AND MEDICAL DISCLAIMER The Participant acknowledges and agrees that the services provided by the Company as part of the Session are intended solely for informational, evaluative, and diagnostic purposes relating to movement and performance parameters. All insights, recommendations, or data interpretations provided are suggestive and do not constitute medical advice, treatment, or prescription.
The Participant further confirms that:
Participation is undertaken voluntarily and at their discretion;
They are medically fit to engage in physical assessments and, where applicable, have disclosed any known health conditions, comorbidities, or prior injuries.
They understand and accept the inherent physical risks associated with biomechanical assessments and waive any claims for injury, illness, discomfort, or lack of performance improvement arising from or in connection with participation in the Session;
The Company shall not be liable for any medical, physiological, or psychological consequences, or failure to meet any athletic, rehabilitation, or performance-related outcomes, except where arising from gross negligence or willful misconduct.
The Participant expressly assumes full responsibility for any consequences arising from participation and releases the Company from any liability in relation to the foregoing.

SECTION 2: MEDIA CONSENT AND WAIVER AGREEMENT
2.1 OBJECT AND SCOPE This section governs the collection, capture, processing, use, reproduction, distribution, and disclosure of visual, audio-visual, photographic, or video recordings (collectively, the "Recording") depicting or featuring the Participant, for purposes including but not limited to external marketing, brand promotion, investor communications, and related commercial dissemination (collectively, the "Marketing Purpose").

2.2 LICENSE AND GRANT OF RIGHTS The Participant hereby irrevocably grants the Company, and its affiliates, successors, assigns, licensees, agents, contractors, and service providers, a perpetual, worldwide, irrevocable, royalty-free, sub-licensable and transferable license to use, reproduce, publish, distribute, adapt, modify, perform, transmit, display, and create derivative works based on the Recording, in whole or in part, across all formats and media now known or hereinafter developed.
This license shall include the right to use such Recording for any and all Marketing Purposes, including but not limited to:
Social and digital media;
Audio-visual campaigns;
Printed publications and newsletters;
Online platforms, including the Company’s website;
Promotional, educational, investor, and commercial materials.

2.3 VOLUNTARY PARTICIPATION AND REVOCATION OF CONSENT The Participant acknowledges that participation is voluntary and may withdraw consent prior to the public dissemination of the Recording.
Withdrawal shall be effected by submitting a formal written request to info@nereustechnologies.com or by dispatch to the Company’s registered address by registered post.
For clarity:
“Public dissemination” shall include publication to external-facing platforms including but not limited to websites, social media accounts, marketing events, or advertisements;
Internal circulation among Company employees, consultants, or medical or technical professionals under contract shall not be deemed public dissemination.
Upon valid withdrawal, the Company shall exercise reasonable efforts to cease further external use of the Recording. However, the Company shall not be obligated to retrieve or remove any Recording that has already been published, distributed, or archived by third-party channels or mirrored platforms.

2.4 NON-ENTITLEMENT TO COMPENSATION The Participant expressly waives any right, title, interest, or claim to monetary compensation or any other form of consideration in respect of the use of the Recording. This waiver shall apply notwithstanding any commercial exploitation, monetization, or value derived by the Company from the use of such Recording.

2.5 DATA PROTECTION AND SECURITY Insofar as the Recording captures information that may qualify as sensitive personal data or information ("SPDI") under applicable Indian law, including facial features, voice, or other biometric identifiers, the Company undertakes to:
Collect, store, and process such data in accordance with the Information Technology Act, 2000, the SPDI Rules, 2011, and the Digital Personal Data Protection Act, 2023;
Implement industry-standard technical and organizational security controls including encryption, access restriction, and data minimization;
Restrict access to authorized personnel under contractual confidentiality obligations.

2.6 REPRESENTATIONS AND WARRANTIES The Participant represents and warrants that:
They are legally competent and above 18 years of age;
Their participation and the grant of rights herein do not infringe the rights of any third party;
No additional consents, approvals, or authorizations are required to effectuate this Agreement;
They have fully reviewed and understood the content and legal implications of this Agreement.

2.7 INDEMNITY The Participant agrees to indemnify, defend, and hold harmless the Company, its affiliates, directors, employees, contractors, and representatives against any and all claims, demands, actions, damages, losses, or liabilities (including reasonable legal costs) arising from:
Any breach of this Agreement;
Any claim by a third party regarding privacy, intellectual property, or personality rights.

2.8 GOVERNING LAW AND JURISDICTION This Agreement shall be governed by, and construed in accordance with, the laws in force in the Republic of India. Any dispute arising out of or in connection with this Agreement shall be subject to the exclusive jurisdiction of the competent courts in Bengaluru, Karnataka.
If the parties are unable to resolve any dispute within thirty (30) days of written notice of dispute, the matter shall be referred to binding arbitration in accordance with the Arbitration and Conciliation Act, 1996, as amended.
The arbitral tribunal shall comprise a sole arbitrator mutually appointed by the parties.
The seat and venue of arbitration shall be Bengaluru, Karnataka.
The language of arbitration shall be English.

2.9 ENTIRE SECTION This section constitutes the entire understanding between the parties in relation to the subject matter hereof and supersedes any prior communications, representations, or arrangements, whether oral or written.
No waiver, modification, or amendment of this Agreement shall be valid unless made in writing and executed by authorized representatives of both parties.

2.10 EXECUTION AND DIGITAL CONSENT Consent is binding upon digital acceptance and confirms legal capacity.

SECTION 3: REFUNDS & CANCELLATION POLICY
3.1 PURPOSE This Refunds & Cancellation Policy (“Policy”) governs the terms under which refunds may be issued for participation in testing sessions (“Sessions”) conducted by Nereus Technologies Private Limited (“Company”, “we”, “our,” or “us”).
By booking a Session and making a payment through our designated platform, you (“Participant”) agree to be bound by the terms set out herein.

3.2 CANCELLATION BY COMPANY  In the event that a scheduled Session is cancelled, rescheduled, or rendered non-operational by the Company due to logistical, operational, safety, or technical reasons, a full refund of the fees paid shall be processed to the original mode of payment within 7 to 10 working days. Alternatively, the Participant may opt to reschedule to an available slot, subject to mutual availability and confirmation.

3.3 CANCELLATION BY PARTICIPANT
Cancellations initiated by the Participant at least 24 hours prior to the scheduled Session will be eligible for a full refund. Cancellations made within 24 hours of the scheduled Session will not be eligible for a refund, except under exceptional emergencies supported by verifiable documentation, at the sole discretion of the Company.

3.4 NON-REFUNDABLE CIRCUMSTANCES 
Refunds shall not be granted under the following circumstances:
No-shows, failure to attend the Session at the designated time and location.
Dissatisfaction with test outcomes, performance insights, or data interpretations provided.
Voluntary withdrawal after the commencement of the Session.
Failure to meet personal expectations, fitness goals, or improvement benchmarks.
Participant’s failure to comply with instructions, protocols, or safety procedures.

3.5 REFUND METHOD AND TIMELINE Refunds, where approved, will be processed to the original payment method (e.g., UPI, bank transfer, credit/debit card) within 7 to 10 working days from the date of written confirmation by the Company.

3.6 CONTACT FOR REFUNDS Requests must be submitted to info@nereustechnologies.com with full name, session date, reason, and supporting documents.

3.7 FRAUD, ABUSE, AND EXCEPTIONS 
The Company reserves the right to deny refund requests that are found to be fraudulent, abusive, repetitive, or inconsistent with the intent and integrity of the Policy.
Refunds shall not be issued in cases of deliberate damage to equipment, misuse of services, or violation of company policies.
Repeated cancellations may result in suspension of access to future Sessions at the Company’s discretion.

3.8 AMENDMENTS 
This Policy may be updated from time to time without prior notice. The latest version shall always be made available on our official website or upon written request.

FINAL CONFIRMATION ☑ I have read, understood, and voluntarily agree to the terms of this Master Participation & Consent Agreement. I confirm that I am above 18 years of age and legally competent to provide this consent.
`}
        </p>
      </div>
    </div>
  )
}
